Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Fibroepithelial

Explore clinical trials studying Neoplasms, Fibroepithelial. Study availability and eligibility vary by location and protocol.

60 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Fibroepithelial trial results

Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01666444

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Winthrop P. Rockefeller Cancer Institute - University of Arkansas Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 136 locations
View Trial Details
Completed

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +41 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 14 locations
View Trial Details
Completed

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

NCT00993616

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +32 more
Locations
  • Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
View all 81 locations
View Trial Details
Completed

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00262847

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +48 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
View all 632 locations
View Trial Details
Completed

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

NCT00085358

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +35 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • Colorado Gynecologic Oncology Group Aurora, Colorado, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Completed

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00079430

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +34 more
Locations
  • University of California Medical Center At Irvine-Orange Campus Orange, California, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 19 locations
View Trial Details
Completed

Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer

NCT00003644

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +22 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Banner Thunderbird Medical Center Glendale, Arizona, United States
  • Banner Good Samaritan Medical Center Phoenix, Arizona, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
View all 151 locations
View Trial Details
Completed

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00939809

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations
  • Georgia Regents University Medical Center Augusta, Georgia, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Nebraska Methodist Hospital Omaha, Nebraska, United States
  • Stony Brook University Medical Center Stony Brook, New York, United States
View all 16 locations
View Trial Details

Related conditions